Literature DB >> 11566589

Computer-modeling-based QSARs for analyzing experimental data on biotransformation and toxicity.

A E Soffers1, M G Boersma, W H Vaes, J Vervoort, B Tyrakowska, J L Hermens, I M Rietjens.   

Abstract

Over the past decades the description of quantitative structure-activity relationships (QSARs) has been undertaken in order to find predictive models and/or mechanistic explanations for chemical as well as biological activities. This includes QSAR studies in toxicology. In an approach beyond the classical QSAR approaches, attempts have been made to define parameters for the QSAR studies on the basis of quantum mechanical computer calculations. The conversion of relatively small xenobiotics within the active sites of biotransformation enzymes can be expected to follow the general rules of chemistry. This makes the description of QSARs on the basis of only one parameter, chosen on the basis of insight in the mechanism, feasible. In contrast, toxicological endpoints can very often be the result of more than one physico-chemical interaction of the compound with the model system of interest. Therefore the description of quantitative structure-toxicity relationships often does not follow a one-descriptor mechanistic approach but starts from the other end, describing QSARs by multi-parameter approaches. The present paper focuses on the possibilities and restrictions of using computer-based QSAR modeling for analyzing experimental toxicological data, with emphasis on examples from the field of biotransformation and toxicity.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11566589     DOI: 10.1016/s0887-2333(01)00060-1

Source DB:  PubMed          Journal:  Toxicol In Vitro        ISSN: 0887-2333            Impact factor:   3.500


  7 in total

1.  Towards a new age of virtual ADME/TOX and multidimensional drug discovery.

Authors:  Sean Ekins; Bruno Boulanger; Peter W Swaan; Maggie A Z Hupcey
Journal:  J Comput Aided Mol Des       Date:  2002 May-Jun       Impact factor: 3.686

2.  Toxicity testing in the 21st century: a vision and a strategy.

Authors:  Daniel Krewski; Daniel Acosta; Melvin Andersen; Henry Anderson; John C Bailar; Kim Boekelheide; Robert Brent; Gail Charnley; Vivian G Cheung; Sidney Green; Karl T Kelsey; Nancy I Kerkvliet; Abby A Li; Lawrence McCray; Otto Meyer; Reid D Patterson; William Pennie; Robert A Scala; Gina M Solomon; Martin Stephens; James Yager; Lauren Zeise
Journal:  J Toxicol Environ Health B Crit Rev       Date:  2010-02       Impact factor: 6.393

3.  Structure-toxicity relationships of nitroaromatic compounds.

Authors:  Olexandr Isayev; Bakhtiyor Rasulev; Leonid Gorb; Jerzy Leszczynski
Journal:  Mol Divers       Date:  2006-05-19       Impact factor: 2.943

4.  Mechanistic insights into the specificity of human cytosolic sulfotransferase 2A1 (hSULT2A1) for hydroxylated polychlorinated biphenyls through the use of fluoro-tagged probes.

Authors:  E J Ekuase; T J van 't Erve; A Rahaman; L W Robertson; M W Duffel; G Luthe
Journal:  Environ Sci Pollut Res Int       Date:  2015-07-14       Impact factor: 4.223

Review 5.  Towards a new age of virtual ADME/TOX and multidimensional drug discovery.

Authors:  Sean Ekins; Bruno Boulanger; Peter W Swaan; Maggie A Z Hupcey
Journal:  Mol Divers       Date:  2002       Impact factor: 2.943

6.  Discovering active sites in peptide Ala-Val-Thr-Phe that counter 2,2-azobis(2-methylpropanimidamidine)dihydrochloride-induced oxidative stress in HepG2 cells.

Authors:  Jiaxi Liang; Qin Wang; Jianliang Liu; Guozhong Huang; Churong Liang; Huifan Liu; Lukai Ma
Journal:  RSC Adv       Date:  2020-06-26       Impact factor: 4.036

7.  Structure-activity models of oral clearance, cytotoxicity, and LD50: a screen for promising anticancer compounds.

Authors:  John C Boik; Robert A Newman
Journal:  BMC Pharmacol       Date:  2008-06-13
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.